Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

United States Antimony (UAMY) Capital Expenditures (2016 - 2025)

United States Antimony's Capital Expenditures history spans 15 years, with the latest figure at $8.7 million for Q3 2025.

  • For Q3 2025, Capital Expenditures rose 11892.72% year-over-year to $8.7 million; the TTM value through Sep 2025 reached $16.3 million, up 3828.44%, while the annual FY2024 figure was $430596.0, 71.83% down from the prior year.
  • Capital Expenditures for Q3 2025 was $8.7 million at United States Antimony, up from $6.5 million in the prior quarter.
  • Across five years, Capital Expenditures topped out at $8.7 million in Q3 2025 and bottomed at $23298.0 in Q1 2021.
  • The 5-year median for Capital Expenditures is $194458.0 (2022), against an average of $1.1 million.
  • The largest annual shift saw Capital Expenditures crashed 89.48% in 2024 before it soared 11892.72% in 2025.
  • A 5-year view of Capital Expenditures shows it stood at $31649.0 in 2021, then surged by 3483.66% to $1.1 million in 2022, then crashed by 83.14% to $191274.0 in 2023, then rose by 8.5% to $207538.0 in 2024, then soared by 4080.04% to $8.7 million in 2025.
  • Per Business Quant, the three most recent readings for UAMY's Capital Expenditures are $8.7 million (Q3 2025), $6.5 million (Q2 2025), and $862511.0 (Q1 2025).